Pharmaceutical Delivery Mechanism TRIZ Cases

Specific once-daily dosing of selective RET inhibitor Compound 1 suppresses RET-driven tumors while improving tolerability over multikinase inhibitors.

A local chitosan-cyclodextrin hydrogel combines analgesic release with joint lubrication to avoid systemic side effects and tissue damage.

Combining a carbonic anhydrase inhibitor with an aldosterone antagonist reduces apneas and hypopneas while lowering dosage needs and side effects.

Targeting the MrgprX2 itch pathway offers a topical or oral approach to reduce atopic dermatitis inflammation and pruritus with fewer side effects.

An aqueous gel coating with an amphiphilic additive keeps urinary catheters lubricious, reduces additive migration, and avoids messy wetting.

Electrospun hybrid-scale fiber matrix particles balance tensile strength with cellular ingrowth for irregular soft tissue repair and wound healing.

Polar-polymer outer layers replace non-polar blends to improve ostomy pouch sealing, odor barrier, strength, and quietness.

An IV sotalol loading dose with QTc and ΔQTc monitoring reaches steady-state Cmax in about 1 hour and shortens hospital stay.

Crosslinked hyaluronic acid particles and TGF-β balance injectability, shape retention, and tissue adhesion for hard tissue repair.

A 15-25 mg estetrol regimen relieves vasomotor and menopause symptoms while limiting hepatic, haemostatic, and metabolic side effects.

Electrospun hybrid-scale fiber particles use mixed fiber densities and compositions to support wound repair without sacrificing tissue integration.

Hybrid-scale graft particles balance tensile strength with cellular ingrowth by varying fiber composition and density for wound repair.

Biodegradable carrier implants enable controlled intratumoral drug release and more uniform tissue exposure than single-point injection.

A sacrificial hydrogel scaffold enables gentle, high-throughput production of prevascularized organoids for angiogenesis and ischemic tissue repair.

A low-water polymer gel stabilizes enzyme and substrate, then generates hydrogen peroxide on dilution for consistent wound antimicrobial action.

A 2.0-2.5 mg/ml octreotide injection balances lower injection volume and preservative load with bioavailability, stability, and efficacy.

A dual-layer membrane uses a cell barrier and mitigation features to limit giant cell formation while supporting vascularization and nutrient diffusion.

Pre-reperfusion malonate salts inhibit succinate oxidation to cut ROS and protect ischemic tissue without waiting for stroke imaging.

A non-toxic oral spray combines synergistic plant extracts and active compounds to inhibit SARS-CoV-2 while avoiding vaccine-related risks.

Hydrophilic grafting lets a dried bioprosthetic heart valve rehydrate quickly and flatten creases, improving pre-loadable handling during use.

A staged intra-arterial then intravenous stem cell regimen improves engraftment in ischemic tissue while limiting off-target cell loss.

A TXA and nitric oxide donor dressing forms rapid fibrin clots, cuts bacterial colonization, and avoids mammalian cell toxicity.

7-Oxozeaenol suppresses RIG-I defenses to improve viral vector gene delivery into NK cells, stem cells, and macrophages with low toxicity.

Balancing pH, solubility, and Hansen solubility parameters helps reservoir drug formulations reduce migration and reactions with device components.

Vacuum flow through a biodegradable nanoporous membrane enables precise scaffold-free cell patterning and rapid release for tissue assembly.

Dual-density nanofibers in a perforated hygiene top sheet wick fluid away from skin and stabilize active ingredients to prevent burst release.

Body-heat-triggered biodegradable capsules release lubricant gradually to reduce mess, avoid reapplication, and provide sustained vaginal moisture.

Age-segmented plasma kallikrein antibody dosing helps reduce hereditary angioedema attack frequency and severity in pediatric patients.

Light-crosslinked zwitterionic copolymer coatings resist protein adsorption and plasticizer leaching on blood-contacting medical surfaces.

Granular hydrogel microparticles are crosslinked and supercritically dried to tune scaffold pore networks for faster cell infiltration.

Autologous PRP or PRF relaxes painful breast implant capsular contracture, offering a less invasive alternative to capsulectomy or capsulotomy.

A layered nanofibrous scaffold with stem-cell hydrogel and growth-factor release supports cartilage and subchondral bone repair with less invasive treatment.

MSC exosomes help counter oxygen-induced thymic involution in neonates by restoring thymic structure, reducing apoptosis, and improving immune function.

Safranal pre-treatment sensitizes chemoresistant liver cancer cells to topoisomerase-1 inhibitors by blocking DNA repair and boosting apoptosis.

Selective AMG 510 dosing targets KRAS G12C tumors while limiting on-target toxicity and supporting durable anti-tumor responses.

Trehalose-rich, low-pH antibody formulations reduce aggregation and maintain high purity at high concentration for ROR1 therapies.

Protective KLA peptide conjugates improve oral biodrug uptake by modulating tight junctions while lowering cytotoxicity and enzyme breakdown.

A dual-solution bone injector mixes and hardens polymer inside bone to raise strength and help prevent contralateral femur fractures.

A dual-drug regimen targets histamine and leukotriene pathways to reduce sepsis severity, toxic shock, and organ failure risk.

Discrete bioabsorbable depots in a bioscaffold encasement release antibiotics over time to reduce implant infection and inflammation.

Self-immolative linkers and triglyceride conjugates improve lymphatic drug transport, release the parent drug efficiently, and boost oral bioavailability.

A hydrophobic-hydrophilic biodegradable copolymer forms nanoparticles that support dermal collagen production without nodule formation.

IL-4 and IL-13 boost induced endothelial cells to improve PAD revascularization and muscle repair while avoiding stem cell fate risks.

Tuning pH and arginine keeps high-concentration anti-IL1R1 antibody formulations injectable while limiting high molecular weight species during storage.

A dual-saccharide or saccharide-acid composition selectively boosts Lactobacilli and suppresses pathogens without disrupting vaginal microflora.

A Trop-2-targeted antibody-drug conjugate improves response in refractory solid tumors while reducing off-target toxicity and adverse reactions.

High-purity EPA ethyl ester added to statins cuts residual cardiovascular event risk without the LDL-C rise seen with mixed omega-3 therapies.

Purified EPA ethyl ester lowers cardiovascular event risk in statin-treated patients without the LDL-C increase seen with mixed omega-3 therapies.

A topical BRAF inhibitor composition treats and prevents EGFR, PI3K, and MEK inhibitor-induced acneiform lesions while preserving cancer therapy.

Freeze-dried cake filler with networked biodegradable particles improves storage stability, disperses uniformly, and lowers injection force.